The Vanguard Group 13D and 13G filings for Co-Diagnostics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Unchanged |
2023-12-29 | 13G | Co-Diagnostics, Inc. CODX |
The Vanguard Group | 1,781,283 5.820% |
0 (Unchanged) |
Filing |
| 2023-02-09 11:15 am Sale |
2022-12-30 | 13G | Co-Diagnostics, Inc. CODX |
The Vanguard Group | 1,781,283 5.760% |
-13,774 (-0.77%) |
Filing |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Co-Diagnostics, Inc. CODX |
The Vanguard Group | 1,795,057 5.300% |
181,173 (+11.23%) |
Filing |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Co-Diagnostics, Inc. CODX |
The Vanguard Group | 1,613,884 5.710% |
1,613,884 (New Position) |
Filing |